Haemonetics Corp. (HAE) Tops Q3 EPS by 3c; Reaffirms Outlook
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $73.27 -1.21%
Revenue Growth %: +2.3%
Financial Fact:
Net income: 0.39
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +2.3%
Financial Fact:
Net income: 0.39
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q3 EPS of $0.50, $0.03 better than the analyst estimate of $0.47. Revenue for the quarter came in at $247.4 million versus the consensus estimate of $251.93 million.
Reaffirmed FY13 and FY14 guidance.
For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.
Reaffirmed FY13 and FY14 guidance.
For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Notice to Long-Term Shareholders of Badger Meter, Inc. (NYSE: BMI); GeneDx Holdings Corp. (NASDAQ: WGS); GRAIL, Inc. (NASDAQ: GRAL); and Verra Mobility Corporation (NASDAQ: VRRM): Grabar Law Office i
- In HelloNation, Wealth Advisor Matt Cuplin Explains How Taxes Affect Retirement Income
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
